Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
7/19/2007
 
First Published:
7/23/2004
1.
Phase II Study of Monoclonal Antibody 3F8, Beta-Glucan, Isotretinoin and Sargramostim (GM-CSF) in Patients With High-Risk Refractory Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
Any age
NCI
MSKCC-04050
NCT00089258
Last Modified:
11/5/2004
 
First Published:
5/1/2002
2.
Phase I Study of beta-Glucan and Monoclonal Antibody 3F8 in Patients With Metastatic Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
Under 50
NCI
MSKCC-01075
NCI-G02-2067, NCT00037011
Last Modified:
9/15/2008
 
First Published:
6/23/2004
3.
Phase I Study of Beta-Glucan and Rituximab in Pediatric Patients With Relapsed or Progressive CD20-Positive Lymphoma or Leukemia or Post-Allogeneic Stem Cell Transplant-Related Lymphoproliferative Disorder
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
Under 22
NCI
MSKCC-03095
NCT00087009
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute